Stocks
Bio-Techne CorporationTECH
NASDAQHealthcareBiotechnology$50.85-1.20%
Specializing in life sciences and clinical diagnostics, this firm provides essential tools for researchers, including proteins, antibodies, and assay kits. With a strong presence in biotech research markets, it attracts investor attention due to consistent growth in the life sciences sector. Its products are widely used in drug discovery and development, making it a key player in biomedical innovation.
Market Cap: $8.0B52W Range: $46.01 – $72.16
Congressional Interest in Bio-Techne Corporation (TECH)
6 members of Congress have disclosed 26 trades in Bio-Techne Corporation (TECH), a Healthcare company. The buy/sell breakdown shows 16 purchases versus 10 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
26
Unique Politicians
6
Buys
16
Sells
10
Who in Congress Is Trading TECH?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-11-03 | JOHN K. DELANEY | buy | $1K – $15K |
| 2015-11-02 | JOHN K. DELANEY | buy | $1K – $15K |